全文获取类型
收费全文 | 139篇 |
免费 | 5篇 |
专业分类
儿科学 | 18篇 |
基础医学 | 4篇 |
临床医学 | 30篇 |
内科学 | 24篇 |
皮肤病学 | 1篇 |
神经病学 | 7篇 |
特种医学 | 2篇 |
外科学 | 6篇 |
综合类 | 1篇 |
预防医学 | 42篇 |
药学 | 7篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 1篇 |
2022年 | 4篇 |
2021年 | 4篇 |
2020年 | 3篇 |
2019年 | 6篇 |
2018年 | 3篇 |
2017年 | 2篇 |
2016年 | 4篇 |
2015年 | 2篇 |
2014年 | 2篇 |
2013年 | 4篇 |
2012年 | 6篇 |
2011年 | 6篇 |
2010年 | 3篇 |
2009年 | 3篇 |
2008年 | 10篇 |
2007年 | 7篇 |
2006年 | 10篇 |
2005年 | 9篇 |
2004年 | 10篇 |
2003年 | 10篇 |
2002年 | 5篇 |
2001年 | 4篇 |
2000年 | 5篇 |
1999年 | 5篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1994年 | 1篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1978年 | 1篇 |
1973年 | 1篇 |
1969年 | 1篇 |
1964年 | 1篇 |
排序方式: 共有144条查询结果,搜索用时 31 毫秒
1.
Ohne Zusammenfassung 相似文献
2.
Abou-Dakn Michael Alexy Ute Beyer Kirsten Cremer Monika Ensenauer Regina Flothkötter Maria Geene Raimund Hellmers Claudia Joisten Christine Koletzko Berthold Mata Jutta Schiffner Ulrich Somm Irene Speck Melanie Weißenborn Anke Wöckel Achim 《Monatsschrift für Kinderheilkunde》2022,170(10):925-928
Monatsschrift Kinderheilkunde - 相似文献
3.
Lisa I. Iezzoni Amy J. Wint Alexy Arauz Boudreau Cheri A. Blauwet Karen A. Kuhlthau 《Disability and health journal》2018,11(3):405-411
Background
Few U.S. studies have explored how children experience a parent's mobility disability and its effects on their daily lives.Objective
We aimed to engage youth ages 13–17 who had at least one parent with mobility disability in describing their perceptions of their parent's disability and its consequences for their daily and family life.Methods
Participants videoed and photographed their experiences following general guidelines from the researchers about topics of interest. Participants made their own choices about what they submitted. We used conventional content analysis to identify broad themes.Results
The mean (standard deviation) age of the 10 participants was 15.2 (1.9) years; 5 were male; 9 participants were white. All 5 girls submitted multiple self-focused (selfie) videos made in their bedrooms; the 5 boys submitted more diverse data files. Several broad themes or topics emerged including: the effects of timing and trajectory of the parent's disability; perceptions of early maturity and responsibility; fears and frustrations relating to the parent's disability; support and emerging resilience; and sense of social justice. Participants generally felt their parents' disability made them become – compared to their peers – more mature, responsible, capable of performing household tasks, and aware of disability civil rights.Conclusions
Participants raised many issues that health care providers should be aware of when youth have parents with mobility disability. A parent's mobility disability may be associated with resilience but also may pose challenges for youth. More research is needed to understand better adolescents' experiences and how clinicians might best assist these youth. 相似文献4.
Laura Jean Podewils Emily Alexy Stephani Jean Driver James E. Cheek Robert C. Holman Dana Haberling Meghan Brett Eugene McCray John T. Redd 《Public health reports (Washington, D.C. : 1974)》2014,129(4):351-360
Objective
We validated cases of active tuberculosis (TB) recorded in the Indian Health Service (IHS) National Patient Information Reporting System (NPIRS) and evaluated the completeness of TB case reporting from IHS facilities to state health departments.Methods
We reviewed the medical records of American Indian/Alaska Native (AI/AN) patients at IHS health facilities who were classified as having active TB using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic codes from 2006 to 2009 for clinical and laboratory evidence of TB disease. Individuals were reclassified as having active TB disease; recent latent TB infection (LTBI); past positive tuberculin skin test (TST) only; or as having no evidence of TB, LTBI, or a past positive TST. We compared validated active TB cases with corresponding state records to determine if they were reported.Results
The study included 596 patients with active TB as per ICD-9-CM codes. Based on chart review, 111 (18.6%) had active TB; 156 (26.2%) had LTBI; 104 (17.4%) had a past positive TST; and 221 (37.1%) had no evidence of TB disease, LTBI, or a past positive TST. Of the 111 confirmed cases of active TB, 89 (80.2%) resided in participating states; 81 of 89 (91.2%) were verified as reported TB cases.Conclusions
ICD-9-CM codes for active TB disease in the IHS NPIRS do not accurately reflect the burden of TB among AI/ANs. Most confirmed active TB cases in the IHS health system were reported to the state; the national TB surveillance system may accurately represent the burden of TB in the AI/AN population.Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis (M. tuberculosis) complex. Treatment for active TB disease requires months of combination drug therapy. Left untreated, TB can result in substantial morbidity and occasionally death. Although the number of TB cases in the United States has steadily declined during the past two decades, TB remains a major health concern within many subgroups, including American Indians/Alaska Natives (AI/ANs). The TB case rate among AI/ANs is estimated at 5.6 per 100,000 population, notably higher than the national average of 3.4 cases per 100,000 population.1Surveillance of active TB disease is an important component of monitoring and controlling the spread of TB. Currently, annual rates of TB in the U.S. are calculated by the Centers for Disease Control and Prevention (CDC) National Tuberculosis Surveillance System (NTSS).1 The NTSS is an electronic database that relies on the collaboration of state and local health departments; each person diagnosed with TB disease is verified as an incident case of TB and reported using a standard TB case form. The criteria for TB disease surveillance are based on a laboratory case definition, clinical case definition, or provider diagnosis.1,2 The laboratory case definition requires isolation of M. tuberculosis complex in culture or detection of M. tuberculosis complex nucleic acids by amplification testing or demonstration of acid-fast bacilli in a clinical specimen when a culture cannot be obtained. The clinical case definition requires (1) a positive tuberculin skin test (TST), (2) signs and symptoms compatible with TB, (3) treatment with at least two anti-TB medications, and (4) a completed diagnostic evaluation. A provider diagnosis is used when the clinical presentation is consistent with TB but the criteria to meet laboratory or clinical case definitions are not met.The Indian Health Service (IHS), an agency of the U.S. Department of Health and Human Services, provides comprehensive health-care services through IHS, Tribal, and Urban Indian facilities (collectively referred to hereafter as IHS) to eligible AI/AN people who are members of 566 federally recognized Tribes. IHS provides care for approximately 2.1 million (62%) of the nation''s estimated 3.4 million AI/ANs.3 The IHS maintains a national database, the National Patient Information Reporting System (NPIRS).4 Within NPIRS, diseases and conditions are coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).5 In addition, IHS is in the process of implementing an electronic health record (EHR) system.6 Electronic data collected by IHS have the potential to serve as a resource to better understand the burden and monitor trends of TB disease within the AI/AN population; yet, the accuracy of NPIRS for identifying people with TB disease has not been previously established. Several previous studies in other U.S. populations have cited wide variability (0%–77%) in the positive predictive value (PPV) of ICD-9-CM diagnostic codes for active TB disease.7–13CDC provides guidance for IHS providers to report all nationally notifiable diseases, including TB, to local and state authorites.1,2 However, there are no explicit mechanisms for IHS to report cases of TB directly to the NTSS, and the extent to which IHS facilities collaborate with local authorities on case reporting is not well understood.We validated active cases of TB disease within the AI/AN population by reviewing the medical charts of individuals assigned an active TB disease ICD-9-CM code in the inpatient and outpatient NPIRS visit data from 2006 to 2009 to determine the completeness of reporting TB disease by examining whether validated TB cases from IHS facilities were reported to state health departments. 相似文献5.
6.
Horvath B Marton Z Halmosi R Alexy T Szapary L Vekasi J Biro Z Habon T Kesmarky G Toth K 《Clinical neuropharmacology》2002,25(1):37-42
Oxygen-free radicals play an important role in several physiologic and pathophysiologic processes. In pathologic circumstances, they can modify and damage biologic systems. Because oxygen-free radicals are involved in a wide range of diseases (cerebrovascular, cardiovascular, etc.), scavenging these radicals should be considered as an important therapeutic approach. In our in vitro study, we investigated the antioxidant capacity of three drugs: pentoxiphylline (Sigma Aldrich, St. Louis, MO, USA) piracetam (Sigma Aldrich), and vinpocetine (Richter Gedeon RT, Budapest, Hungary). Phenazine methosulphate was applied to generate free radicals, increasing red blood cell rigidity. Filtration technique and potassium leaking were used to detect the cellular damage and the scavenging effect of the examined drugs. According to our results, at human therapeutic serum concentration, only vinpocetine (Richter Gedeon RT) had significant (p < 0.01) scavenging activity with a protective effect that increased further at higher concentrations. Pentoxiphylline (Sigma Aldrich) and piracetam (Sigma Aldrich) did not have significant antioxidant capacity at therapeutic concentrations, but increasing their concentrations (pentoxiphylline at 100-times, and piracetam at 10-times higher concentrations) led to a significant (p < 0.01) scavenger effect. Our findings suggest that this pronounced antioxidant effect of vinpocetine and even the milder scavenging capacity of pentoxiphylline and piracetam may be of value in the treatment of patients with cerebrovascular disorders, but merits further investigations. 相似文献
7.
Crystal deposition in a case of cutaneous Rosai-Dorfman disease 总被引:2,自引:0,他引:2
Motta L McMenamin ME Thomas MA Calonje E 《The American Journal of dermatopathology》2005,27(4):339-342
Rosai-Dorfman Disease (RDD) is an idiopathic reactive proliferation of distinctive histiocytes that have abundant cytoplasm and commonly exhibit intracytoplasmic ingestion of inflammatory cells (emperipolesis). The histiocytes are immunopositive for S100 protein and are typically associated with an infiltrate of lymphocytes, plasma cells, and neutrophils. The classic clinical presentation is massive enlargement of (usually) cervical lymph nodes with a histologic appearance that mimics exaggerated sinus histiocytosis. RDD can also involve extra-nodal sites and skin involvement is common either as part of disseminated disease or as a result of primary disease. We report an exceptional case of cutaneous RDD with crystal deposition in a young male presenting with skin nodules. Skin biopsy showed classic features of cutaneous RDD with the additional feature of conspicuous rhomboidal and needle-shaped crystals within the cytoplasm of many lesional plasma cells, histiocytes, and also in an extra-cellular location. The plasma cells were polyclonal by light chain immunostaining. Crystal deposition has not been reported to date in RDD and is likely a result of the reactive plasma cell proliferation. 相似文献
8.
Szapary L Horvath B Marton Z Alexy T Kesmarky G Habon T Szots M Koltai K Juricskay I Czopf J Toth K 《CNS drugs》2004,18(3):165-172
9.
The study was aimed to elucidate whether the dissimilar effects of concurrent presentation of sweet water on alcohol consumption previously reported for Wistar rats from different sources remain unchanged when alcohol is also flavored with 0.1% saccharin. Male Wistar rats from Laboratory of Experimental Biological Models (LEBM) and Krukovo animal farm (K) stocks having had 2 months free access to food, tap water, and 10% alcohol were given four consecutive two-bottle drinking tests: alcohol versus water, alcohol versus sweet water, sweet alcohol versus water, or sweet alcohol versus sweet water. The test order was quasi-random and each test lasted 4 days. In Wistar (K) rats, flavoring of either water or alcohol solution increased consumption of each of the fluids and decreased intake of concurrently available fluids. The elevation in water intake induced by its sweetening was antagonized by flavoring of alcohol solution. In Wistar (LEBM) rats, flavoring of either water or alcohol increased consumption of each of the fluid, but did not change the intake of alternative fluids. The stable alcohol consumption by Wistar (LEBM) rats and its suppression seen in Wistar (K) rats induced by concurrent presentation of flavored water parallel the patterns previously observed among P, sP, and HAD rats suggesting the existence among alcohol-consuming animals of typological diversity of alcohol motivation. 相似文献
10.
This study examined the outcome measures of readmission to the hospital and change in functional status/quality of life. Patients were admitted to the hospital most commonly by the 15th visit indicating complications arise soon after home care initiation. Implications for more specific data related to acuity, family support, and outcomes are suggested to develop and evaluate strategies for cost-effective care. The potential for preventing hospitalizations may be diminished due to the cost containment strategies currently used by agencies in response to PPS. 相似文献